The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Understanding the Association of Apolipoprotein E4 with Alzheimer Disease: Clues from Its Structure
Open accessAbstract
Despite intense interest, the molecular mechanisms underlying the association of apoE4 with Alzheimer disease are not clear. Because the function (or dysfunction) of a protein is based on its structure, this review focuses on the effects of the structural differences among the isoforms on neurodegeneration. Understanding how apoE4 structure impacts neurodegeneration is likely to provide mechanistic insight as well as potential therapeutic approaches to blunt or reduce its effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ApoE has two structural domains, an N-terminal domain, which is responsible for interaction with ApoE receptors, and a C-terminal domain, which is responsible for lipoprotein binding [68].”
From ApoE, ApoE Receptors, and the Synapse in Alzheimer's Disease (2017) · cites this paper as [68]
In the citing paper
“ApoE exists in the human population in three isoforms, which differ at only two residues, 112 and 158. ApoE2 has a cysteine at both positions, ApoE3 has a cysteine at position 112 and an arginine at position 158, and ApoE4 has arginines at both positions [68].”
From ApoE, ApoE Receptors, and the Synapse in Alzheimer's Disease (2017) · cites this paper as [68]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Melnick, V. L., & Dubler, N. N. (1985) · Contemporary Issues in Biomedicine, Ethics, and Society · doi:10.1007/978-1-4612-5174-3 · Cited by 1,986
Schmechel, D. E., Saunders, A. M., Strittmatter, W. J., Crain, B. J., Hulette, C. M., Joo, S. H., Pericak-Vance, M. A., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9649 · Cited by 1,525
Molten Globule and Protein Folding
Ptitsyn, O. B. (1995) · Advances in protein chemistry · doi:10.1016/s0065-3233(08)60546-x · Cited by 1,222
Holtzman, D. M., Bales, K. R., Tenkova, T., Fagan, A. M., Parsadanian, M., Sartorius, L. J., Mackey, B., Olney, J., McKeel, D., Wozniak, D., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050004797 · Cited by 937
Mahley, R. W., Weisgraber, K. H., & Huang, Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600549103 · Cited by 912
Self-citationApolipoprotein E: Structure-Function Relationships
Weisgraber, K. H. (1994) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60642-7 · Cited by 830
Self-citationApolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid
Wisniewski, T., & Frangione, B. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90444-c · Cited by 802
Flagged first, then by citations
Research works printed but not linked: 1
- Wisniewski, 1994, Am. J. Pathol., 145, 1030
Cited by
Sorted by citations
Items 101–158 of 158
Neuroinflammation drives APOE genotype-dependent differential expression of neprilysin
Graykowski, D. R., Kasparian, K., Caniglia, J. L., Gritsaeva, Y., & Cudaback, E. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577315 · Cited by 12
Pontifex, M. G., Martinsen, A., Saleh, R. N. M., Harden, G., Fox, C., Müller, M. M., Vauzour, D., & Minihane, A. M. (2022) · Nutrients · doi:10.3390/nu14091698 · Cited by 13
Gillet, J.-N. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1784287 · Cited by 8
Genetic Variation in the Ontario Neurodegenerative Disease Research Initiative
Dilliott, A. A., Evans, E. C., Farhan, S. M. K., Ghani, M., Sato, C., Zhang, M., McIntyre, A. D., Cao, H., Racacho, L., Robinson, J. F., et al. (2019) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2019.228 · Cited by 8
Shaji, D., Das, A., Suzuki, R., Nagura, Y., Sabishiro, H., & Kurita, N. (2023) · Biophysical Chemistry · doi:10.1016/j.bpc.2023.106990 · Cited by 7
Conformational Reorganization of Apolipoprotein E Triggered by Phospholipid Assembly
Prakashchand, D. D., & Mondal, J. (2021) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.1c03011 · Cited by 7
Frisardi, V. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111568 · Cited by 7
New APOE-related therapeutic options for Alzheimer’s disease
Li, Z. (2019) · AIP conference proceedings · doi:10.1063/1.5085515 · Cited by 8
The Role of Genetics in Alzheimer's Disease and Parkinson's Disease
Porter, T., Gozt, A., Mastaglia, F. L., & Laws, S. M. (2019) · Wiley eBooks · doi:10.1002/9781119356752.ch15 · Cited by 6
Unraveling APOE4: The dual role in CNS and peripheral inflammation in Alzheimer's disease
Li, X., Li, Z., Chen, H., Guo, H., Ge, Y., Dong, F., Zhang, F., & Zhang, F. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115199 · Cited by 7
Jiang, F., Wang, N., & Meng, Q. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251360321 · Cited by 6
Future Treatment of Alzheimer Disease
Keskin, A. O., Durmaz, N., Uncu, G., Erzurumluoglu, E., Yıldırım, Z., Tuncer, N., & Adapınar, D. Ö. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.85096 · Cited by 6
Targeting apolipoprotein E for treating Alzheimer’s disease
Bales, K. R., & Paul, S. M. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134366 · Cited by 7
Vignesh, R., Sjölander, A., Venkatraman, G., Rayala, S. K., & Aradhyam, G. K. (2021) · Biochemical Journal · doi:10.1042/bcj20210016 · Cited by 6
Zhou, S., & Sun, X. (2012) · PubMed · Cited by 5
Full-length apolipoprotein E protects against the neurotoxicity of an apoE-related peptide
Crutcher, K. A., Lilley, H. N., Anthony, S., Zhou, W., & Narayanaswami, V. (2009) · Brain Research · doi:10.1016/j.brainres.2009.10.021 · Cited by 5
Key Enzymes and Proteins in Amyloid-Beta Production and Clearance
Santos, C. R. A., Cardoso, I., & Gonçalves, I. (2011) · InTech eBooks · doi:10.5772/17646 · Cited by 5
Intérêt du régime cétogène dans la prise en charge de la maladie d’Alzheimer
Charlot, A., Lernould, A., Plus, I., & Zoll, J. (2023) · Biologie Aujourd hui · doi:10.1051/jbio/2023031 · Cited by 2
Molecular etiopathogenesis of neurodegenerative diseases
Divya, D., Thekkekkara, D., Sai, T. E., Ramakrishna, D., Manjula, S. N., & Goswami, S. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-28822-7.00002-7 · Cited by 2
The neuronal functions of human apolipoprotein E
Ong, Q., & Wong, B. (2013) · OA Biochemistry · doi:10.13172/2052-9651-1-1-442 · Cited by 2
CASE REPORT OF A PATIENT WITH RARE P.ARG136CYS (APOE2*) MUTATION IN APOLIPOPROTEIN E GENE
Lisyova (2014) · OnLine Journal of Biological Sciences · doi:10.3844/ojbsci.2014.36.43 · Cited by 2
Türk Popülasyonunda APOE Polimorfizmleri ve Alzheimer Hastalığı Arasındaki İlişki
Çilingir, O., Adapınar, B. D. Ö., Aras, B. D., Gökalp, E. E., Özkan, S., Arslan, S., Haziyeva, K., Kocagil, S., Bilgin, M., & Artan, S. (2019) · OSMANGAZİ JOURNAL OF MEDICINE · doi:10.20515/otd.553900 · Cited by 2
Apolipoprotein M – Studies of Structure and Function
Ahnström, J. (2009) · Lund University Publications (Lund University) · Cited by 2
Netrin-1 as a molecular mediator linking APOE ε4 to alzheimer’s disease pathogenesis
He, B., Fu, Z., Liang, Y., Liang, J., Zeng, D., Zhong, Y., Chen, H., & Wang, X. (2025) · Scientific Reports · doi:10.1038/s41598-025-19693-1 · Cited by 1
Genetic Factors in Alzheimer Disease and Dementia
Bird, T. D. (2009) · Springer eBooks · doi:10.1007/978-3-540-37654-5_28 · Cited by 1
Guardia-Escote, L. (2019) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Tomic, I., Hao, S. P., & Tomić, A. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.23.619445 · Cited by 1
Inhibition of ApoE4 Endocytosis with LDLR-LA PeptidesPreprint
Park, S. H., Gomes, G.-N. W., Beyer, B. A., & Levine, Z. A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.20.726622 · Cited by 1
Gau, B. C. (2011) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k72r3pq8
ABCA1, Apoe and apoA-I As Potential Therapeutic Targets for Treating Alzheimer’s Disease
Namjoshi, D., Stukas, S. K., & Wellington, C. L. (2011) · Neurodegenerative Disease Management · doi:10.2217/nmt.11.23
Reinforcement Learning, Error-Related Negativity, and Genetic Risk for Alzheimer's Disease
Figueroa, C. M. (2016) · e-Publications@Marquette (Marquette University)
Munger, E. L. (2016) · OhioLink ETD Center (Ohio Library and Information Network)
Genes, Aging, and Parkinson’s Disease
Milanese, C., & Mastroberardino, P. G. (2017) · Royal Society of Chemistry eBooks · doi:10.1039/9781782622888-00389
Castranio, E. L. (2018) · D-Scholarship@Pitt (University of Pittsburgh)
A novel Lipid-Carrier Initiator prion hypothesisPreprint
Reddy, K. (2020) · doi:10.22541/au.158870182.20724084
The interactive impact of omega-3 fatty acids, APOE genotype and sex hormones on cognition
Pontifex, M. G. (2020) · UEA Digital Repository (University of East Anglia)
Horie, N. C. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2015.tde-11052015-114427
Marques, R. B. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2021.tde-06122021-121359
Perspective Chapter: Alzheimer - A Complex Genetic Background
Calabrò, M., & Crisafulli, C. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.101455
Meyer, B. J. (2018) · MDPI eBooks · doi:10.3390/books978-3-03842-972-2
Wang, Y., Kong, X.-Z., Guan, B., Zheng, C.-H., & Gao, Y.-L. (2023) · Lecture notes in computer science · doi:10.1007/978-981-99-4749-2_28
Asociación entre enfermedad periodontal y enfermedad de Alzheimer
García-Vásquez, A. T., Vidal-Chávez, S. R., Anccasi-Zevallos, M., Franco-Quispe, G. A., Ramos-Perfecto, D., & Mattos-Vela, M. A. (2023) · Bionatura · doi:10.21931/rb/2023.08.04.26
Martin, W., & Cheng, F. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4705580
Relationship Between Dyslipidemia and Alzheimer’s Disease
Bolayırlı, M., & Kücür, M. (2024) · doi:10.69860/nobel.9786053359166.12
The biochemical pathways of Alzheimer's disease
El-Gammal, M. A., & Kodous, F. E. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15702-8.00001-4
APOE, Pesticides, Environmental Pollutants, and Epigenetics
Biosca-Brull, J., Colomina, M. T., Cabré, M., & Guardia-Escote, L. (2025) · Springer eBooks · doi:10.1007/978-3-031-52641-1_50-1
ApoE and Methylmercury Intoxication
Bittencourt, L. O., Aschner, M., & Lima, R. R. (2025) · Springer eBooks · doi:10.1007/978-3-031-52641-1_45-1
Rôle des ADAM dans le processus physiopathologique de la maladie d'Alzheimer
Laumet, G. O. (2010) · theses.fr (ABES) · doi:10.70675/94126786zf990z488ezb471z5f1d5686766c
ApoE and Methylmercury Intoxication
Bittencourt, L. O., Aschner, M., & Lima, R. R. (2026) · Springer eBooks · doi:10.1007/978-3-031-96089-5_45
Gillet, J.-N. (2026) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2026.2671163
Apolipoprotein E and infectious diseases: A framework for therapeutic developments
Viswalingam, V., Kumar, D., Tewari, S., & Ganeshpurkar, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40563-1.00018-1
Vecino, R., Díaz‐Guerra, E., Arribas-González, E., Gil, D. S., Acosta, F. J. F., Serra, I., Moreno‐Jiménez, E. P., Moratalla, R., Navarrete, M., & Vicario‐Abejón, C. (2026) · Research Square · doi:10.21203/rs.3.rs-10968101/v1
Namba, N., Ariyoshi, S., Shimba, A., Shiroshita, H., Ohgita, T., & Saito, H. (2026) · ACS Omega · doi:10.1021/acsomega.6c09295
Metadata
- Authors
- Zhong, N., & Weisgraber, K. H.
- Affiliations
- Gladstone Institutes (US)
- Corresponding author
- Weisgraber, Karl H.
- ORCID
- Zhong, Ning
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2009-03
- Volume
- 284
- Issue
- 10
- Pages
- 6027-6031
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC2649104
- OpenAlex
- W2007282102
- Cited by
- 159
- References
- 43
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 7 · 2023: 7 · 2022: 5 · 2021: 8 · 2020: 13 · 2019: 14 · 2018: 4 · 2017: 6 · 2016: 9 · 2015: 4 · 2014: 12 · 2013: 8 · 2012: 11
- FWCI
- 1.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Alzheimer's Association
- American Health Assistance Foundation
- Gladstone Institutes
- National Institutes of Health (CO6 RR0118928, AG‐022074)
- National Institute on Aging (P01AG022074)
- National Center for Research Resources (C06 RR0118928)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- APOE ε4, Alzheimer's disease, APOE isoforms, protein structure, neurodegeneration, molecular mechanisms, therapeutic target
- MeSH terms
- Alzheimer Disease, Animals, Humans, Structure-Activity Relationship, Protein Structure, Tertiary, Protein Isoforms, Apolipoprotein E4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review